Childhood Obesity Conferences | Meetings | Events | USA | Europe | Middle East | Asia Pacific

Theme: To Unfold the Intricacy of being fit

Childhood Obesity 2016

Scientific Program

Renowned Speakers

Susan Farus-Brown
Ohio University School of Nursing, USA

Analia S Loria
Universtiy of Kentucky, Lexington, USA

Cristina Campoy
University of Granada. Spain

Chunmei Shi
Nanjing Maternal and Child Health Hospital
China

Gerry Leisman
National Institute for Brain and Rehabilitation Sciences in Nazareth, Israel

Sanaa Mohamoud Ahmed
Minia University
Egypt

Linhua Zhao
Guangâ€™ anmen Hospital of China Academy of Chinese Medical Science
China

Shaweta Vasudeva
Aerobics and Fitness Association of America
USA

Childhood Obesity 2016

ConferenceSeries LLC Ltd Conferences invites all the participants from all over the world to attend 'International Conference on Childhood Obesity' during August 29-30, 2016 in Atlanta, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Childhood Obesity 2016 is a global platform to discuss and learn about Childhood Obesity Prevention Strategies & Polices, Child Nutrition, Behavioural and Environmental factors causing Obesity, Preventing Obesity from Pregnancy & Infancy, Paediatric Infectobesity, Endocrine Disorders & Diabetes in Children, Paediatric obesity surgery, Impact of obesity on Neurodegenerative Diseases, Impacts of Steroids, Hormones, Antibodies and Vaccines on Overweight, Effects on joints, muscles, Kidney, Heart, Respiratory tract, Mushroom Supplements, Exercise & Kinesiology, Childhood obesity Prevention in Underserved Communities, Diagnosis & Treatments, Healthcare at Affordable Price.

Track 1: Childhood Obesity Prevention

Food policy is the area of public policy concerning how food is produced, processed, distributed, and purchased. Many Childhood Obesity prevention Strategies and policies have been proposed to counter obesity and some of those proposed policies focus on altering the food system to influence dietary habits and thus obesity and nutrition by changing the choices available to consumers or by changing the incentives to choose. To reverse the obesity epidemic, places and practices need to support healthy eating and active living. The recommended strategies for obesity prevention are Early Care, Nutrition Education Strategies, Physical Education Strategies, School Health Guidelines to Promote Healthy Eating, Physical Activity and School-Based Childhood Obesity Prevention Strategies- School Lunch Programs, After-School Programs.

2nd International Conference on Food Safety and Regulatory Measures June 06-08, 2016, UK; Spain; 11th Global Summit and Expo on Food & Beverages September 22-24, 2016, USA; 2nd International Conference on Sports Medicine and Fitness April 18-20, 2016, UAE; Endocrinology Conferences October 10-12, 2016 Manchester, UK;6th Global Healthcare & Fitness Summit August 22-24, 2016, USA; 4th International Conference and Exhibition on Nutrition and Food Sciences October 26-28 2016, USA; 4th International conference on Weight loss and Fitness Expo November 21-23, 2016, UAE; 3rd Global Experts Meeting on Weight Loss and Medicare Expo September 19-21, 2016, Austria; Obesity Conferences Nov 14-15, 2016 Dubai, UAE; 18th International Conference on Overweight and Obesity March 1-2, 2016, USA; The XIII International Conference on Obesity, May 1-4, 2016 Canada; Obesity and Adipose Tissue Biology February 15-19, 2016, Canada; 18th International Conference on Obesity May 23 - 24, 2016, UK

Track 2: Child Nutrition

A healthy diet helps children grow and learn. It also helps obesity prevention and weight-related diseases, such as diabetes. Healthy eating can stabilize children’s energy, sharpen their minds, and even out their moods. While peer pressure and TV commercials for junk food can make getting kids to eat well seem impossible, Encouraging healthy eating behavior in children make a huge impact on their lifelong relationship with food choice and give them the best opportunity to grow into healthy, confident adults.

5th International Conference on Clinical Nutrition December 05-07, 2016, USA; 2nd World Nutraceutical Conference and Expo July 11-13, 2016, Malaysia; 18th International Conference on Nutrition and Food Sciences July 21 - 22, 2016, Switzerland; International Conference on Advances in Human Nutrition, Food Science & Technology June 26-27, 2016,Canada; 18th International Conference on Human Nutrition and Food Sciences September 15 - 16, 2016, Italy; ASN Scientific Sessions at Experimental Biology April 2-6, 2016, California; Endocrinology Conferences October 10-12, 2016 Manchester, UK; International Conference on Sports Nutrition and Supplements July 11-13, 2016, USA; 2nd International Conference on Livestock Nutrition July 21-22, 2016, Australia; Obesity Medical Conferences Nov 14-15, 2016 Dubai, UAE; 2nd World Pharm Nutrition and Nutraceutical Conference and Expo July 18-20, 2016, Thailand

Track 3: Childhood Obesity

In order to understand Childhood Obesity, the mechanisms those underlie the etiology of obesity, molecular basis of obesity, cellular basis and genetics of obesity are needed to elucidate. The study of extreme human obesity caused by a single gene defects has provided a glimpse into the long-term regulation of body weight. More analysis of the wide-ranging effects of obesity will help researchers pinpoint the neurological implications and work to find ways for obesity prevention.

World Congress on Obesity August 08-10, 2016, Canada; 3rd Global Experts Meeting on Weight Loss and Medicare Expo September 19-21, 2016, Austria; Endocrinology Conferences October 10-12, 2016 Manchester, UK; The XIII International Conference on Obesity, May 1-4, 2016 Canada; 2nd Fetal Medicine, Paediatric Gastro, Hepatology & Nutrition Conference 25–27 February 2016, UAE; International Conference and Exhibition on Lung & Respiratory Care August 01-03, 2016, UK; 5th Global Respiratory and Pulmonologist Annual Meeting November 17-18, 2016, UAE; 2nd International Conference on Sleep Disorders and Medicine November 28-30, 2016, USA; Type 2 Diabetes, Metabolic Syndrome and Obesity May 24 – June 2 2016, 5th International Conference and Exhibition on Cell and Gene Therapy May 19-21, 2016, USA 12th Biotechnology Congress November 14-15, 2016, USA; World Congress on Human Genetics October 31- November 02, 2016, Spain; International Conference on Clinical and Molecular Genetics November 28-30, 2016 Chicago, USA; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE;

Track 4: Rheumatic Diseases

A study found that childhood obesity was significantly associated with adult knee pain in men and childhood weight and body mass index (BMI) were associated with stiffness and dysfunction. Subjects who were overweight in both childhood and adult life had a significant increase in the adulthood walking knee pain compared with those who had normal weight in both childhood and adult life. These associations were most notable in males. These indicate the importance of reducing childhood obesity in preventing adulthood knee symptoms.

5th International Conference of Orthopedic Surgeons and Rheumatology March 31-April 01, 2016, Spain; 7th Global Orthopedicians Annual Meeting October 20-22, 2016, Malaysia; Podiatrist Meeting on Foot and Ankle Surgery August 15-16, 2016, USA; Rheumatology, Chronic Pain, Diabetes and Obesity May 17-31, 2016, Hungary; 2016 CRA Annual Scientific Meeting & AHPA Annual Meeting February 17-20, 2016, Canada; 2016 World Congress on Osteoarthritis March 31-April 3, Netherlands; Endocrinology Conferences October 10-12, 2016 Manchester, UK; International Conference and Exhibition on Transplantation Research & Techniques March 29-30, 2016, USA; International Conference and Exhibition on Plastic and Reconstructive Surgery October 03-05, 2016, USA; International Conference on Vascular Medicine and Surgeons Meeting October 24-25, 2016, USA; Annual European Congress of Rheumatology June 8-11, 2016, UK; 9th Interdisciplinary World Congress on Low Back and Pelvic Girdle Pain September 21-24, 2016, Singapore; Annual European Congress of Rheumatology June 14-17, 2016, Spain; Obesity Conferences Nov 14-15, 2016 Dubai, UAE;

Track 5: Behavioural & Environmental Factors

The past few decades have brought lifestyle changes throughout the world that have resulted in children having reduced physical activity and increased caloric intake. The amount of time that children spend playing outside has diminished during the past few decades and physical education, nutrition education programs in schools have been reduced or eliminated. Living a sedentary lifestyle, children are spending more time watching television and playing on computers than exercising. Both physical activity and nutrition-focused interventions are already in place in many primary schools. Self-monitoring, increasing sports and physical activity are few of the psychological and behaviour change strategies to treat the disease of obesity either alone or in conjunction with other treatments.

4th Global Experts Meeting on Neuropharmacology September 15-17, 2016, USA; International Conference on Counselling Psychology December 08-10, 2016 San Antonio, USA; Endocrinology Conferences October 10-12, 2016 Manchester, UK; 21st Annual AFPA Fitness, Trainer, Sports and Mind Body Conference May 13-15, 2016, USA; Global Clinical Psychologists Annual Meeting October 10-12, 2016, Malaysia; Eating Disorders Congress August 15-16, 2016, USA; International Conference on Cognitive Behavioral Therapy June 13-15, 2016, USA; International Conference on Positive Psychology June 13-14, 2016, USA; 4th International Conference on Psychiatrist and Geriatric Psychiatry December 08-10, 2016, USA; Obesity Medical Conferences Nov 14-15, 2016 Dubai, UAE; International Conference on Counselling Psychology December 08-10, 2016, USA; International Conference on Psychosomatic Medicine November 10-12, 2016, Spain;

Track 6: Chronic Kidney Disease

Obesity is not only comorbidity for chronic kidney disease (CKD) but may also be a risk factor for CKD. Epidemiological correlations and pathophysiological changes have been observed associating obesity with CKD. Low birth weight may be associated with both obesity and low nephron mass, leading to CKD later in life. Elevated levels of adipokines, such as leptin and adiponectin, in obesity may be factors in CKD pathogenesis and progression. Furthermore, various other factors, such as hypertension, increased cardiovascular morbidity, insulin resistance, dyslipidemia, and lipotoxicity, may play significant roles in the pathogenesis of CKD in obesity. Reduction in obesity, which is a potentially modifiable risk factor, might help decrease the burden of CKD in the population. Apart from individualized options, community-based interventions have the potential to create a strong impact in this condition.

International Conference on Kidney Transplantation September 29-October 01, 2016, USA; International Conference on Vascular Medicine and Surgeons Meeting October 24-25, 2016, USA; Endocrinology Conferences October 10-12, 2016 Manchester, UK; 5th Global Nephrologists Annual Meeting March 31-April 02, 2016, Spain; The 15th Asian Pacific Congress of Nephrology (APCN) and ANZSN ASM, September 17-21 2016, Australia; 4th International Conference on Pre Hypertension, Hypertension and CMS 3–6 March 2016, Italy; Annual Meeting on Paediatric Nephrology May 9-11, 2016, USA; 6th Annual Conference on Clinical Nephrology May 9-11, 2016, USA; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE; 10th International Conference on Nephrology & Therapeutics September 29-October 01, 2016, USA; APCN/ ANZSN 17 Sep 2016-21 Sep 2016, Australia;

Track 7: Preventing Obesity from Infancy

Research on the prenatal period and first year of life point to clues to reduce obesity in women and preventing it in children. The researchers pointed to excessive gestational weight gain, maternal smoking during pregnancy, fewer months of breastfeeding and shorter duration of sleep during infancy as potential targets. Factors associated with increased risk for overweight or obesity in infancy and early childhood include excessive maternal weight gain or smoking during gestation, maternal depression shorter-than-recommended duration of breast-feeding, and suboptimal amounts of sleep during infancy.

4th International Conference on Weight Loss and Fitness Expo November 21-23, 2016, UAE; Pregnancy Summit & Child Health August 29-31, 2016, Brazil; 5th International Conference on Clinical Nutrition December 05-07, 2016 San Antonio, USA; 2nd World Pharm Nutrition and Nutraceutical Conference and Expo July 18-20, 2016, Thailand; European Nutrition and Dietetics Conference June 16-18, 2016, Italy; XX Biennial International Conference on Infant Studies May 26-28, 2016, USA; International Conference on Infant Studies May 26 - 29, 2016, USA; Endocrinology Conferences October 10-12, 2016 Manchester, UK; The 15^TH World Congress of the World Association for Infant Mental Health May 29 - June 2, 2016, Czech Republic; 20th Biennial International Conference on Infant Studies 26 - 28 May 2016 USA; Obesity Conferences Nov 14-15, 2016 Dubai, UAE; International Society On Early Intervention Conference: Children's Rights and Early Intervention June 8-10, 2016, Sweden;

Track 8: Pulmonary Function, Allergy & Immunity

Asthma is one of the most common significant chronic diseases affecting children. The number of people worldwide affected by asthma may be as high as 300 million. The high degree of heritability, external factors such as air pollution, immune sensitization, nutrition and obesity can affect disease risk. Obesity is associated with reduced quality of life and excess risk for several chronic diseases. The change in obesity prevalence in recent decades has been greatest among children. Obesity-related comorbidites such as gastroesophageal reflux and sleep apnea have yet to be conclusively linked to increased asthma risk in children.

2nd International Conference on Respiratory and Pulmonary Medicine May 09-10, 2016, USA; 3rd International Conference on Chronic Obstructive Pulmonary Disease July 11-12, 2016, Australia; 4th International Conference and Exhibition on Lung & Respiratory Care August 01-03, 2016, UK; 5th Global Respiratory and Pulmonologist Annual Meeting November 17-18, 2016, UAE; 2nd International Conference on Sleep Disorders and Medicine November 28-30, 2016, USA; The 2016 Sleep Summit November 22, 2016, UK; Endocrinology Conferences October 10-12, 2016 Manchester, UK; 3rd International Conference on Chronic Obstructive Pulmonary Disease July 11-12, 2016, Australia; 2nd World Congress on Infectious Diseases August 25-27, 2016, USA; 4th International Conference on Epidemiology and Public Health October 03-05, 2016, UK; 2nd International Conference on Influenza September 12-14, 2016, Germany; Obesity Medical Conferences Nov 14-15, 2016 Dubai; Thomas L. Petty Aspen Lung Conference - Lung Transplantation: Opportunities for Repair and Regeneration 8–11 June 2016, USA; Respiratory Health and Smoking Science Summit 2016 24–26 May 2016, UK; 17th World Conference on Lung Cancer 2016 04 Dec 2016 → 07 Dec 2016, Austria;

Track 9: Paediatric Infectobesity

In addition to the imbalance between energy intake and expenditure, sedentary lifestyle, a diet high in saturated fats and sugars, and genetic predisposition, many other factors may be involved in obesity. The presence of either symbiotic or pathogenic microorganisms may contribute to the development of obesity. Gut microorganisms are believed to be involved in the development of obesity by two different and complementary mechanisms. They can extract energy from non-digestible polysaccharides and produce low-grade inflammation. Although the primary cause of obesity will always be a misbalance between energy intake and expenditure, its association with microbiology is only a small demonstration of how complex this multifactorial condition is. Nevertheless, beneficial microorganisms as well as pathogenic microorganisms deserve more attention as evidence of their contribution to metabolic disorders continues to accumulate.

International Conference on Food Microbiology August 08-10, 2016, UK; 2nd World Congress on Beneficial Microbes: Food, Pharma, Aqua & Beverages Industry September 23-25, 2016, USA; International Allergy Conference March 29-30, 2016, Spain; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Functional and Medical Foods, Bioactive Compounds and Biomarkers November 17-18, 2015, Japan; Parasitic Infection 2016, June 28 – 30, 2016, UK; Food Allergy Summit 2016 July 5-7, 2016, UK; FARE National Food Allergy Conference May 14-15, 2016, USA; WAO International Scientific Conference 6-9 December 2016, Israel; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE; Mexican National Congress Of Clinical Immunology And Allergy 2016 MAY 18-21, 2016, Mexico; Eastern Allergy Conference 2016 June 2-5, 2016, USA;

Track 10: Lifelong effects

Childhood obesity can have a harmful effect on the body in a variety of ways. Obese children are more likely to have High blood pressure and high cholesterol, which are risk factors for cardiovascular diseases (CVD). In one study, 70 percent of obese children had at least one CVD risk factor, while 39 percent had two or more. Increased risk of impaired glucose tolerance, insulin resistance and type 2 diabetes. Breathing problems, such as sleep apnea and asthma. Joint problems and musculoskeletal discomfort. Fatty liver disease, gallstones and gastro-esophageal reflux (i.e., heartburn). If children are overweight, obesity in adulthood is likely to be more severe.

World Congress on Obesity August 08-10, 2016, Canada; 7th Health Care and Fitness Summit September 26-28, 2016, UK; 6th Global Healthcare & Fitness Summit August 22-24, 2016, USA; World Congress on Public Health and Nutrition March 10-12, 2016, Spain; 4th Asia-Pacific Global Summit & Expo on Healthcare July 18-20, 2016, Australia; Endocrinology Conferences October 10-12, 2016 Manchester, UK; 6th Asian Obesity Specialists & Endocrinologists Annual Meeting July 11-13, 2016, Malaysia; 3rd Global Experts Meeting on Weight Loss and Medicare Expo September 19-21, 2016, Austria; 5th Global Respiratory and Pulmonologist Annual Meeting November 17-18, 2016, UAE; 2nd International Conference on Sleep Disorders and Medicine November 28-30, 2016, USA; Type2 Diabetes, Metabolic Syndrome and Obesity May 24 – June 2 2016, Denmark; Obesity Conferences Nov 14-15, 2016 Dubai, UAE; 4^th Food Allergy and Anaphylaxis Meeting October 13-15, 2016, Italy;

Track 11: Endocrine Disorders & Diabetes

Several endocrine abnormalities are reported in obesity. In case of certain disorders, endocrine glands metabolism slows down and the body does not spend taken calories. This is typical for all individuals suffering from hypothyroidism. They are prone to weight gain although they might not have changed their eating habits and do not consume high-caloric foods. Another endocrine disorder associated with obesity is Cushing's disease. It develops due to excess of cortisol, a hormone produced by the cortex of the adrenal gland. Hypopituitarism is one more endocrine dysfunction that may be blamed for obesity. The reason why hypopituitarism leads to obesity is not completely understood.

Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity to produce enough insulin in the pancreas. It is associated with modifiable lifestyle risk factors and also has strong genetic and family related risk factors. It is managed with a combination of regular physical activity, healthy eating and weight reduction. As type 2 diabetes is often progressive, most people will need oral medications and/or insulin injections in addition to lifestyle changes.

11th Asia Pacific Diabetes Conference and Expo July 11-13, 2016, Australia; 9th Global Diabetologists Annual Meeting and Medicare Expo June 06-08, 2016, USA; Endocrinology Conferences October 10-12, 2016 Manchester, UK; International Conference on Pediatric Endocrinology September 15-17, 2016, USA; Metabolic & Endocrine Disease Summit, October 7-10, 2015, USA; 85th Annual Meeting of the American Thyroid Association (ATA) 21–25 September 2016, USA; Type 2 Diabetes, Metabolic Syndrome and Obesity May 24 – June 2 2016, Denmark; Obesity Medical Conferences Nov 14-15, 2016 Dubai, UAE; 4th Euro Obesity & Endocrinology Specialists Annual Meeting March 29-31, 2016, Spain; 12th Diabetes Meeting and Therapeutics Expo September 29-October 01, 2016, Canada; 2nd Global Summit on Hormones and Steroids June 23-25, 2016, USA; 9th Diabetologists Conference June 06-08, 2016, USA; International Conference on Metabolic Syndromes October 20-22, 2016, UAE; 13th Global Diabetes Conference & Medicare Expo August 08-10, 2016, UK; 14th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19, 2016 Kuala Lumpur, Malaysia; Advanced Technologies & Treatments for Diabetes (ATTD 2016) 3–6 February 2016, Italy; Obesity and Adipose Tissue Biology 15–19 February 2016, Canada; Ernährung 2016 9–11 June 2016, Germany; 21st Century Diabetes Management Update Western Caribbean Cruise 12–19 June 2016, USA; Rare Metabolic Disorders: Detection, Research, Management and Treatment 20–22 September 2016, UK; 85th Annual Meeting of the American Thyroid Association (ATA) 21–25 September 2016, USA; Arab Diabetes Medical Congress 6–8 October 2016, Qatar; Endocrinology: An Update and Refresher for the PCP Eastern Caribbean Cruise Co-Sponsored w/School of Medicine 9–16 October 2016, USA

Track 12: Obesity Surgery

The prevalence of morbid obesity has risen sharply in recent years, even among paediatric patients. Bariatric surgery is used increasingly in an effort to induce weight loss, improve medical comorbidities, enhance quality of life, and extend survival. Every effort is made to achieve non-surgical weight loss, but for a small group of children, medical, behavioural and nutritional approaches to weight loss may not be enough. Due to the considerable lifestyle changes surgery will bring about, the family and child must continue to commit to a strict program of healthy eating and exercise before he or she can be a candidate for surgery.

4th International Conference on Weight Loss and Fitness Expo November 21-23, 2016, UAE; International Conference and Exhibition on Medical-Surgical Nursing October 13-15, 2016, Malaysia; 3rd Global Experts Meeting on Weight Loss and Medicare Expo September 19-21, 2016, Austria; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE; Obesity and Chronic Disease July 25-27, 2016, USA; 7th World Cardiothoracic Meeting March 29-30, 2016, USA; International Conference and Exhibition on Plastic and Reconstructive Surgery October 03-05, 2016, USA; 7th Health Care and Fitness Summit September 26-28, 2016, UK; 3rd Global Experts Meeting on Weight Loss and Medicare Expo September 19-21, 2016, Austria; Annual Meeting of the German Society of Neurosurgery (DGNC) 12–15 June 2016; Germany

Track 13: Impact of Steroids & Hormones

Hormones are chemical messengers that regulate processes in our body. They are one factor in causing obesity. The hormones leptin and insulin, sex hormones and growth hormone influence our appetite, metabolism and body fat distribution. People who are obese have levels of these hormones that encourage abnormal metabolism and the accumulation of body fat. A system of glands, known as the endocrine system, secretes hormones into our bloodstream. The endocrine system works with the nervous system and the immune system to help our body cope with different events and stresses. Excesses or deficits of hormones can lead to obesity and on the other hand, obesity can lead to changes in hormones.

2nd Global Summit on Hormones and Steroids June 23-25, 2016, USA; 13th Global Diabetes Conference & Medicare Expo August 08-10, 2016, UK; 11th Asia Pacific Diabetes Conference and Expo July 11-13, 2016, Australia; 12th Diabetes Meeting and Therapeutics Expo September 29-October 1, 2016, Canada; 6th Global Diabetes Summit and Medicare Expo November 02-04, 2015, UAE; Endocrinology Conferences October 10-12, 2016 Manchester, UK; 7th Annual Academic Sessions Endocrine Society of Sri Lanka, October 1-4, 2015, Sri Lanka; 9th Diabetologists Conference June 06-08, 2016, USA; International Conference on Metabolic Syndromes October 20-22, 2016, UAE; Obesity Conferences Nov 14-15, 2016 Dubai, UAE; Ernährung 2016 9–11 June 2016, Germany; 21st Century Diabetes Management Update Western Caribbean Cruise 12–19 June 2016, USA; Rare Metabolic Disorders: Detection, Research, Management and Treatment 20–22 September 2016, UK; 85th Annual Meeting of the American Thyroid Association (ATA) 21–25 September 2016, USA; Arab Diabetes Medical Congress 6–8 October 2016, Qatar; Endocrinology: An Update and Refresher for the PCP Eastern Caribbean Cruise Co-Sponsored w/School of Medicine 9–16 October 2016, USA

Track 14: Childhood Obesity at Gene Level

Obesity tracks in families, and one of the strongest predictors of child overweight is the BMI of the mother and father. In recent years, progress was made in identifying genes that may contribute to this effect. The FTO (fat mass and obesity-associated) gene is a large gene on chromosome 16. The absolute risk generated by the FTO gene is relatively modest, is found in Caucasian populations, and is modifiable by environmental factors. The Human Obesity Gene Map summarizes the present situation in the field of common polygenic obesity. The genes include members of the leptin–melanocortin pathway, proinflammatory cytokines and uncoupling proteins. The largest numbers of studies have been carried out on ADRB2 (β2 adrenoreceptor) and PPARG (Peroxisome Proliferator-Activated Receptor Gamma) a Protein Coding gene, but the fact that they also have reported associations with asthma and Type 2 Diabetes, respectively.

5th International Conference and Exhibition on Cell and Gene Therapy May 19-21, 2016, USA 12th Biotechnology Congress November 14-15, 2016, USA; World Congress on Human Genetics October 31- November 02, 2016, Spain; International Conference on Clinical and Molecular Genetics November 28-30, 2016 Chicago, USA; Endocrinology Conferences October 10-12, 2016 Manchester, UK; World Congress on Human Genetics October 31- November 02, 2016 Valencia, Spain; International Conference on Clinical and Molecular Genetics November 28-30, 2016, USA; 6th International Conference on Genomics & Pharmacogenomics September 12-14, 2016, Germany; 4^th International Conference on Plant Genomics July 14-15, 2016, Australia; AGT Annual Meeting 2016 - Association of Genetic Technologists June 23-25, 2016, USA; 57th Annual Drosophila Research Conference - Genetics Society Of America July 13-17, 2016, USA; TAGC 2016 - The Allied Genetics Conference July 13-17, 2016, USA; 35th NSGC Annual Education Conference (AEC) - National Society Of Genetic Counselors Sep 28-Oct 1, 2016, USA; Obesity Medical Conferences Nov 14-15, 2016 Dubai, UAE; ASHG Annual Meeting 2016 - American Society of Human Genetics October 18-22, 2016, Canada; 2017 ACMG Annual Clinical Genetics Meeting - American College Of Medical Genetics & Genomics March 21-25, 2017, USA

Track 15: Diagnosis & Treatments

Calculation of child's body mass index (BMI) determines where it falls on the BMI-for-age growth chart. The BMI helps indicate if your child is overweight for his or her age and height. Treatment for childhood obesity is based on your child's age and if he or she has other medical conditions. Treatment usually includes changes in your child's diet and level of physical activity. In certain circumstances, treatment may include medications or weight-loss surgery. Weight-loss surgery may be an option for severely obese adolescents who have been unable to lose weight using conventional weight-loss methods. However, as with any type of surgery, there are potential risks and long-term complications. Also, the long-term effects of weight-loss surgery on future growth and development are largely unknown.

International Conference on Medical Imaging & Diagnosis May 09-10, 2016, USA; 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016, Turkey; 2nd International Conference and Exhibition on Molecular Medicine and Diagnostics September 26-28, 2016, USA; International Conference on Internal Medicine November 03-05, 2016 Baltimore, Maryland, USA; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Treating Depression 2016 March 14, 2016, UK; 11th Annual CADDRA ADHD Conference October 17-18, Canada; 14th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19, 2016, Malaysia; 12th Diabetes Meeting and Therapeutics Expo September 29-October 01, 2016, Canada; 9th Diabetologists Conference June 06-08, 2016, USA; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE; International Conference and Exhibition on Dual Diagnosis July 21-22, 2016, USA; Cancer Diagnostics Conference & Expo June 13-15, 2016, Italy

Track 16: Impact on Neurodegenerative Diseases

Neurodegenerative disorders are amongst the leading causes of worldwide disability, morbidity and decreased quality of life. They are increasingly associated with the concomitant worldwide epidemic of obesity. Although the prevalence of both AD and PD continue to rise, the available treatment strategies to combat these conditions remain ineffective against an increase in global neurodegenerative risk factors. Obesity is associated with several pathologies including neuropathies and the ability of the nervous system to repair following injury. While further research is needed in characterizing the nature of the effect of obesity on the nervous system, there are current studies suggesting that such effects can be modified.

5th World Congress on Neurology and Therapeutics March 14-16, 2016, UK; 2nd Annual Experts Meeting on Depression, Anxiety and Stress Management November 03-04, 2016, Spain; 4th Global Experts Meeting on Neuropharmacology September 15-17, 2016, USA; Biology of Down Syndrome: Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE; International Conference on Sleepspindling 12-14 May 2016, Hungary; 23rd Annual International Stress And Behavior Neuroscience and Biopsychiatry Conference 16-19 May 2016, Russian Federation; State of the Brain 22-26 May 2016, Austria; 2nd International Conference on Brain Disorders and Therapeutics October 27-29, 2016, USA; 9th Global Neuroscience Conference November 07-09, 2016, Australia; Bipolar Disorders Conference August 22-23, 2016, Brazil; 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery August 01-03, 2016, Germany; 2nd International Conference on Epilepsy & Treatment October 24-26, 2016, Italy; International Conference on Neuro Informatics September 29-October 01, 2016, Spain; 4th International Conference on Vascular Dementia June 30 - July 02, 2016, Spain

Track 17: Visceral & Gastrointestinal Disorders

Obesity is also associated with a number of GI and hepatobiliary conditions. Recent study report: waist circumference and waist–hip ratio were strongly associated with the presence of Barrett's esophagus, albeit in males only. Another recent report also demonstrated an association of visceral fat and fat near the gastroesophageal junction with Barrett's, and with increased esophageal inflammation and high-grade dysplasia in Barrett's patients, independent of BMI. Obesity, the metabolic syndrome and rapid weight loss are modifiable risk factors of gallstone formation. Obesity is also associated with an increased risk of the spectrum of non-alcoholic fatty liver diseases (NAFLD) including simple steatosis, non-alcoholic steatohepatitis, cirrhosis and hepatocellular carcinoma.

6th Gastroenterology and Gastroenterologists Annual Meeting June 16-18, 2016, USA; 7th Global Gastroenterologists Meeting August 11-12, 2016, UK; International Conference on Pancreatic Disorders and Treatment May 12-14, 2016 Chicago, USA; European Gastroenterology Conference October 24-26, 2016, Spain; International Conference on Clinical Gastroenterology & Hepatology October 03-05, 2016, Canada; Digestive Diseases Week, May 21-24, 2016, USA; Endocrinology Conferences October 10-12, 2016 Manchester, UK; 3rd World Congress on Hepatitis and Liver Diseases October 17-19, 2016, UAE; 2nd International Conference on Hepatology May 09-11, 2016 Chicago, USA; International Conference on Endoscopy November 17-19, 2016, USA; International Conference on Clinical Gastroenterology & Hepatology October 03-05, 2016, Canada; 2nd Microbiome R&D and Business Collaboration Congress: Obesity Medical Conferences Nov 14-15, 2016 Dubai, UAE; Digestive Disease Week (DDW) 21–24 May 2016, USA; 10th Congress of the International Society of Nutrigenetics & Nutrigenomics (ISNN) 23–26 May 2016, Israel; Parasitic Infection 2016 28–30 June 2016, UK; Medical Ethics and Legal Medicine Bermuda Cruise 31 July – 7 August 2016, USA; Topics in Gastroenterology and Rheumatology for the PCP Greece, Turkey and Malta Cruise 7–18 August 2016, Italy; Rare Metabolic Disorders: Detection, Research, Management And Treatment 20–22 September 2016, UK; The Power of Programming 2016 - International Conference of Developmental Origins of Adiposity and Long-Term Health 13–15 October 2016, Germany

Track 18: Vaccines for Obesity

Obesity causes many problems in humans, but the treatment options for obesity are very limited. It is widely accepted that a combination of dieting and physical activity is the most effective way of reducing obesity. However, these methods are highly dependent on the motivation of individual subjects. Recent studies have shown that therapeutic vaccines may be new targets for the development of anti-obesity medication. The therapeutic vaccines could treat alternatively the obesity by suppressing the appetite-stimulating hormone and blocking absorption of nutrients. Active vaccination against target molecules is another therapeutic vaccine approach. The recombinant virus-like particle (VLP) has a similar structure to viruses but lacks sufficient genetic information to replicate. Thus, this type of vaccine is less dangerous compared with live virus vaccines.

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016, Italy; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination November 10-12, 2016, Australia; International Conference on Hepatitis Vaccines September 26-28, 2016, Spain; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Annual Conference on H1N1 & Influenza Vaccines September 12-14, 2016, USA; Children vaccines world congress October 10-12, 2016, Malaysia; Annual Conference on Virulent HIV Vaccines October 03-05, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo October 20-22, 2016, Turkey; Vaccine Technology VI June 12-17, 2016, Portugal; 2016 National Conference on Immunization Coalitions & Partnerships May 25–27, 2016, USA; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE; ACIP Meeting June 22–23, 2016, USA; 2016 North Dakota State Immunization Conference August 3–4, 2016, USA; ACIP Meeting October 19–20, 2016, USA

Track 19: Mushroom Supplement

A supplement from the Ganoderma lucidum mushroom slowed the pace of weight gain by apparently altering bacteria inside the digestive system of mice. Chinese medicine has used a number of different mushrooms to treat a variety of conditions over thousands of years. One of these is called reishi, or Ganoderma lucidum, which is believed to improve health and lifespan. It has also been tested as a possible cancer treatment as some research has suggested it is beneficial to the immune system.

International Conference on Plant Physiology June 09-11, 2016, 5th International Conference on Agriculture & Horticulture June 27-29, 2016, South Africa; 18th ISMS conference International Society for Mushroom Science May 29 - June 2, 2016, Netherlands; 34th Dutch Mushroom Days, June 01 - 03, 2016, The Netherlands; World Congress on Public Health and Nutrition March 10-12, 2016, Spain; International Conference on Advances in Human Nutrition, Food Science & Technology June 26-27, 2016,Canada; 3rd International Conference on Food Security and Nutrition March 23-25, 2016, Netherlands; 18th International Conference on Human Nutrition and Food Sciences September 15 - 16, 2016, Italy; 2nd Fetal Medicine, Paediatric Gastro, Hepatology & Nutrition Conference 25–27 February 2016, UAE; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE; International Conference on Sports Nutrition and Supplements July 11-13, 2016, USA; 2nd International Conference on Livestock Nutrition July 21-22, 2016, Australia; 2nd World Pharm Nutrition and Nutraceutical Conference and Expo July 18-20, 2016, Thailand

Track 20: Antibiotics and Obesity

New research has suggested a link between the use of antibiotics in infants during the first 2 years of life and later childhood obesity. It is known that antibiotics alter gut microbiota and it has been postulated that this alters metabolism, which may lead to obesity. However, despite three cohort studies to date that suggest this link exists, the evidence so far is weak and a direct causal relationship has not been established. Even organic vegetables have antibiotics in them because about 75 percent of antibiotics fed to livestock are excreted out, and in the manure used to fertilize fields. The only way this can change is if the multinational food industry stops using antibiotics for growth purposes.

2nd International Conference and Exhibition on Antibodies July 14-15, 2016, USA; 2nd World Congress and Exhibition on Antibiotics October 13-15, 2016, UK; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Annual Conference on H1N1 & Influenza Vaccines September 12-14, 2016, USA; Children vaccines world congress October 10-12, 2016, Malaysia; Annual Conference on Virulent HIV Vaccines October 03-05, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo October 20-22, 2016, Turkey; Vaccine Technology VI June 12-17, 2016, Portugal; Obesity Conferences Nov 14-15, 2016 Dubai, UAE; 2016 National Conference on Immunization Coalitions & Partnerships May 25–27, 2016, USA; ACIP Meeting June 22–23, 2016, USA; 2016 North Dakota State Immunization Conference August 3–4, 2016, USA; ACIP Meeting October 19–20, 2016, USA

Track 21: Cardiac Functional Changes

Changes in cardiac geometry and function resulting from obesity are observed as early as childhood, according to the results of a new study. The relationship between obesity and cardiovascular risk is difficult to assess because obesity is associated with glucose intolerance, diabetes, high blood pressure, and elevated cholesterol levels. Compared with the nonobese group, the obese children had thicker LV walls, a 29% larger LV end-diastolic volume, and a 40% larger LV mass. Left atrial (LA) volume, LA volume index, right atrial area, and right ventricular diameter were also significantly larger in the obese children. The differences remained after adjustment for physical development and growth, although the indexed LV systolic and diastolic diameters were similar between the two groups.

9th International Conference on Molecular & Cellular Cardiology August 22-24, 2016, Brazil; 2nd International Conference and Exhibition on Pediatric Cardiology September 22-24, 2016, USA; 8th Global Cardiologists Annual Meeting July 18-20, 2016, Germany; 12th World Cardiology Congress October 10-12, 2016 Manchester, UK; International Conference on Hypertension & Treatment August 04-06, 2016 Toronto, Canada; Endocrinology Conferences October 10-12, 2016 Manchester, UK; International Conference and Exhibition on Plastic and Reconstructive Surgery October 03-05, 2016, USA; 7th Health Care and Fitness Summit September 26-28, 2016, UK; 3rd Global Experts Meeting on Weight Loss and Medicare Expo September 19-21, 2016, Austria; Obesity Conferences Nov 14-15, 2016 Dubai, UAE;

Track 22: Current Studies

Our recent study provides definitive evidence that drinking sugar-sweetened beverages directly impacts weight gain and paediatric obesity. Obesity Prevention Center suggests that all calories are not alike from a metabolic perspective. Reducing consumption of highly processed carbohydrates – like white bread, white rice, refined breakfast cereals, and sugary beverages – can provide a metabolic boost of several hundred calories a day, equal to an hour of physical activity. This metabolic boost may be a key to successful long-term weight loss maintenance. Genetics and Endocrinology, analysed data from about 90,000 people, they discovered six new genetic variants linked with body mass index. Most of the variants highlight genes active in the brain, suggesting that differences in appetite regulation may play a role in obesity. The team is now performing larger-scale studies in an attempt to identify additional genetic variants with the goal of one day developing an effective treatment for obesity.

5th International Conference and Exhibition on Metabolomics May 16-18, 2016, Japan; 5th International Conference on Tissue Science and Regenerative Medicine September 12-14, 2016, Germany; International Conference on Precision Medicine November 03-05, 2016, USA; International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care July 25-27, 2016, Thailand; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medical Conferences Nov 14-15, 2016 Dubai, UAE; 4th Asia-Pacific Global Summit & Expo on Healthcare July 18-20, 2016, Australia; 6th Global Healthcare & Fitness Summit August 22-24, 2016, USA; Global Health Economics Summit July 25-26, 2016, Germany; 2ndAnnual Congress & Medicare Expo on Primary Healthcare September 15-17, 2016, USA; 5th International Conference and Exhibition on Metabolomics May 16-18, 2016, Japan;

Track 23: Healthcare

Few studies had quantified the impact of obesity on healthcare utilization, costs and expenditures during childhood. Analyses of the economic consequences of childhood obesity had previously also largely been limited to the USA. Overweight children had annual total healthcare expenditures US$180 higher than children with a normal BMI, while obese children had US$220 higher expenditures on average. Large investments through research and prevention are needed and are likely to provide strong returns in cost savings.

4th Asia-Pacific Global Summit & Expo on Healthcare July 18-20, 2016, Australia; 6th Global Healthcare & Fitness Summit August 22-24, 2016, USA; Global Health Economics Summit July 25-26, 2016, Germany; 2ndAnnual Congress & Medicare Expo on Primary Healthcare September 15-17, 2016, USA; J.P. Morgan 34th Annual Healthcare Conference January 11-15, 2016, USA; 5th International Conference and Exhibition on Metabolomics May 16-18, 2016, Japan; Endocrinology Conferences October 10-12, 2016 Manchester, UK; 5th International Conference on Tissue Science and Regenerative Medicine September 12-14, 2016, Germany; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE; International Conference on Precision Medicine November 03-05, 2016, USA; International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care July 25-27, 2016, Thailand;

Track 24: Exercise & kinesiology

Physical exercise is any bodily activity that enhances or maintains physical fitness and overall health and wellness. It can improve your health and reduce the risk of developing several diseases like type 2 diabetes, cancer and cardiovascular disease and have immediate and long-term health benefits. Most importantly, regular activity can improve your quality of life. A minimum of 30 minutes a day can allow you to enjoy the benefits of life.

4th International Conference and Exhibition on Physical Medicine & Rehabilitation August 25-27, 2016, USA; Pregnancy Summit & Child Health August 29-31, 2016, Brazil; 7th Health Care and Fitness Summit September 26-28, 2016, UK; 6th Global Healthcare & Fitness Summit August 22-24, 2016, USA; Endocrinology Conferences October 10-12, 2016 Manchester, UK; 4th International Conference on Weight Loss and Fitness Expo November 21-23, 2016, UAE; IDEA World Fitness Convention, July 13-17, 2016, USA; 21st Annual AFPA Fitness, Trainer, Sports and Mind Body Conference May 13-15, 2016, USA; Obesity Conferences Nov 14-15, 2016 Dubai, UAE; 3rd Indo-Global Summit & Expo on Healthcare October 05-07, 2015, India; 4th Asia-Pacific Global Summit & Expo on Healthcare July 18-20, 2016, Australia; 6th Global Healthcare & Fitness Summit August 22-24, 2016, USA; Global Health Economics Summit July 25-26, 2016, Germany; 2ndAnnual Congress & Medicare Expo on Primary Healthcare September 15-17, 2016, USA;

Track 25: Biomedical Engineering and Obesity

The obesity solutions were primarily in three areas: devices, materials, and information management. Biomedical engineering community developed devices for minimally invasive surgery for laparoscopy to implantation and endoscopy with suturing device for gastric treatment and related applications. Signalling devices, implantable and wearable devices for monitoring purposes was also developed. New and innovative engineering approaches need to address clinical problems related to energy balance, intake, and expenditure. Novel sensors, devices, imaging, and other technologies, including technologies to detect biochemical markers of energy balance are expected to be developed and evaluated by collaborating engineers, physical scientists, mathematicians, and scientists from other relevant disciplines with expertise in obesity and nutrition.

9th World Drug Delivery Summit June 30-July 02, 2016, USA; 7th International Conference and Exhibition on Pharmacovigilance & Clinical Trials September 19-21, 2016, Austria; 14th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19, 2016, Malaysia; Endocrinology Conferences October 10-12, 2016 Manchester, UK; 7th International Conference on Biomarkers & Clinical Research November 28-30, 2016, USA; 2nd International Conference on Clinical Trials August 22-24, 2016, USA; Obesity Conferences Nov 14-15, 2016 Dubai, UAE; 7th International Conference and Exhibition on Pharmacovigilance & Clinical Trials September 19-21, 2016, Austria; 5th Global Summit on Toxicology & Applied Pharmacology September 19-21, 2016 Las Vegas, USA; 6th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 29- Oct 01, 2016, USA; 5th International Conference and Exhibition on Metabolomics May 16-18, 2016, Japan; Clinical Trials Europe May 17-18, 2016, France; SCT 37th Annual Meeting (2016), May 15-18, 2016, Canada; 5th Annual Clinical Trials and Development Asia Congress January 2016, China

Track 26: Undeserved Communities

Underserved communities have the highest need for built environment interventions because they are characterized by limited financial resources and poor infrastructure. There is a lack of ready access to healthy foods (i.e., fruits, vegetables, whole grains and lean protein). Families in poorer communities often live in food deserts where supermarkets and grocery stores are scarce or charge higher prices for healthy foods than processed foods. To make matters worse, many underserved communities, particularly in urban areas, have an overabundance of fast food establishments that are often located near schools and playgrounds. Multidisciplinary approach can reduce obesity rates by creating healthy living environments that promote the transition from healthful intention to healthful behaviour.

World Congress on Health & Medical Sociology September 06-07, Italy; 2nd Annual Congress & Medicare Expo on Primary Healthcare September 15-17, 2016, USA; 6th Global Healthcare & Fitness Summit August 22-24, 2016 Philadelphia, USA; World Congress on Public Health and Nutrition March 10-12, 2016, Spain; 4th International Conference on Epidemiology and Public Health October 03-05, 2016, UK; AAC&U's Annual Meeting, January 20-23, 2016, USA; Endocrinology Conferences October 10-12, 2016 Manchester, UK; 4th Asia-Pacific Global Summit & Expo on Healthcare July 18-20, 2016, Australia; 6th Global Healthcare & Fitness Summit August 22-24, 2016, USA; Global Health Economics Summit July 25-26, 2016, Germany; 2ndAnnual Congress & Medicare Expo on Primary Healthcare September 15-17, 2016, USA; 5th International Conference and Exhibition on Metabolomics May 16-18, 2016, Japan; Obesity Conferences Nov 14-15, 2016 Dubai, UAE; 5th International Conference on Tissue Science and Regenerative Medicine September 12-14, 2016, Germany; International Conference on Precision Medicine November 03-05, 2016, USA; International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care July 25-27, 2016, Thailand; 4th International Conference on Translational Medicine October 26-28, 2015, USA;

Track 27: Clinical Research

Applicant institutions are designing and conducting randomized controlled trials to test innovative prevention or treatment interventions that are preceded by pilot studies. The two obesity prevention trials will develop and test approaches that target home, community, and primary care settings for preschool children living in low income and ethnically diverse neighbourhoods. The two obesity treatment trials will examine obesity therapies for overweight and obese children 7 to 16 years old in school and home settings in collaboration with local youth organizations. The ultimate goal is prevention of future obesity-related morbidity and mortality.

7th International Conference on Biomarkers & Clinical Research November 28-30, 2016, USA; 2nd International Conference on Clinical Trials August 22-24, 2016, USA; 7th International & Clinical Trials Conference and Exhibition on Pharmacovigilance September 19-21, 2016, Austria; 5th Global Summit on Toxicology & Applied Pharmacology September 19-21, 2016 Las Vegas, USA; 6th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 29- Oct 01, 2016, USA; 5th International Conference and Exhibition on Metabolomics May 16-18, 2016, Japan; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Clinical Trials Europe May 17-18, 2016, France; SCT 37th Annual Meeting (2016), May 15-18, 2016, Canada; International Conference on Precision Medicine November 03-05, 2016, USA; International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care July 25-27, 2016, Thailand; Genomics and Personalized Medicine February 7-11, 2016, Canada; Obesity Medical Conferences Nov 14-15, 2016 Dubai, UAE; 4th Asia-Pacific Global Summit & Expo on Healthcare July 18-20, 2016, Australia; 6th Global Healthcare & Fitness Summit August 22-24, 2016, USA; Global Health Economics Summit July 25-26, 2016, Germany; 2ndAnnual Congress & Medicare Expo on Primary Healthcare September 15-17, 2016, USA; 5th International Conference and Exhibition on Metabolomics May 16-18, 2016, Japan;

Track 28: Child Obesity Statistics

Childhood obesity has more than doubled in children and quadrupled in adolescents in the past 30 years. The percentage of children aged 6–11 years in the United States who were obese increased from 7% in 1980 to nearly 18% in 2012. Similarly, the percentage of adolescents aged 12–19 years who were obese increased from 5% to nearly 21% over the same period. This percentage is increasing in an alarming mode which is ultimately leading to several other body diseases at such a tender age. To reduce child obesity, there should be proper planned health diet for the children a regular physical exercise is also needed in order to improve the condition in a better way.

2nd International Conference on Clinical Trials August 22-24, 2016, USA; 5th International Conference on Forensic Research & Technology November 17-19, 2016, USA; Endocrinology Conferences October 10-12, 2016 Manchester, UK; 2nd Researchers - Statisticians and Young Statisticians Congress May 3-11, 2016, Italy; 12th International Conference on Order Statistical Data May 25-28, 2016, Greece; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE; European Conference on Quality in Official Statistics June 1-3, 2016, Spain; 5th International Conference on Establishment Statistics June 20-23, 2016, Switzerland; Bernoulli World Congress July 11-15, 2016, USA; Second International Conference on Survey Methods in Multinational, Multiregional and Multicultural Contexts July 25-29, 2016, USA; 13th Iranian Statistical Conference August 24-28, 2016, Iran

Conference Series LLC Ltd Conferences invites all the participants from all over the world to attend 'International Conference on Childhood Obesity' during August 29-30, 2016 in Atlanta, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Childhood Obesity 2016 is a global platform to discuss and learn about obesity & its related areas of medicine & health care. Which includes overview, prevalence, trends and disparities of obesity, causes of obesity, obesity and its associated health problems, co-dependent relationship between diabetes & obesity, childhood obesity and its effects on physical and mental health, diagnosis/screening of obesity and associated health ailments, obesity and weight management, surgical and non- surgical methods, preventive approaches of obesity, economics of obesity & it's prevention, legal and policy interventions to counteract obesity and endocrinology and metabolism disorders. Main theme of this conference is "To Unfold the Intricacy of being fit"

Childhood Obesity Prevention will require both a personal and social/cultural change in lifestyle. A large volume of current research will help clarify what will be most helpful. Hope Childhood Obesity 2016 would make it half the way.

Join us as we continue to share and discuss emerging research, best practices, community-based efforts and effective policy strategies that promote and sustain healthy eating and physical activity practices for children, adolescents and their families!

Why to Attend

With members from around the world focused on learning about obesity and its advances; this is your best opportunity to reach the largest assemblage of participants from the obesity community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in obesity are hallmarks of this conference

Target Audience

· Endocrinologists

· Obesity specialists

· Bariatric surgeons

· Nutritionists

· Early childhood and after school providers

· Food system professionals

· Dieticians

· Fitness experts

· Policy Makers

Summary

Childhood Obesity 2016 welcomes attendees, presenters, and exhibitors from all over the world to Atlanta, USA. We are delighted to invite you all to attend and register for the “International Conference on Childhood Obesity (Childhood Obesity 2016)” which is going to be held during August 29-30, 2016 at Atlanta, USA. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops, poster presentations and various programs for participants from all over the world. We invite you to join us at the Childhood Obesity 2016, where you will be sure to have a meaningful experience with scholars from around the world for the paradigm of a healthy child. Childhood Obesity 2016 organising committee looking forward for your presence in Atlanta, USA.

For more details please visit: http://childhoodobesity.conferenceseries.com/

Importance and Scope

Childhood obesity is a serious medical condition that affects children and adolescents. It occurs when a child is well above the normal weight for his or her age and height. As methods to determine body fat directly are difficult, the diagnosis of obesity is often based on Body Mass Index BMI. Due to the rising prevalence of obesity in children and its many adverse health effects it is being recognized as a serious public health concern. The vast majority of obesity represents an imbalance in calories ingested versus calories expended. Genetic factors, environmental factors, lifestyle preferences, and cultural factors seem to play major role in the rising prevalence of obesity worldwide. The effects of obesity on children have a huge impact and can range from low self-esteem to increased risk of cardiovascular diseases. The most effective cure for childhood obesity is prevention.

Childhood obesity prevention will require both a personal and social/cultural change in lifestyle. A large volume of current research will help clarify what will be most helpful. Hope Childhood Obesity 2016 would make it half the way.

Why Atlanta

Atlanta has been involved actively in the childhood obesity programs making a difference in the childhood obesity epidemic. Each year Center Helping Obesity in Children End Successfully, Inc. (CHOICES), based in Kennesaw and downtown Atlanta, hosts two expos to bring health education into underserved communities. The program’s focus is on nutrition education and physical activity in order to help children maintain a healthy weight. They provide year round programs for families and present special events with community partners. The Children's Healthcare of Atlanta's Strong4Life program combines a fun camp, parent involvement and healthy education for kids struggling with their weight. The Active Schools Acceleration Project (ASAP) is an entrepreneurial non-profit focused on increasing quality physical activity in schools. The organization will provide $1,000 to 1,000 schools ($1 million total) across the country to help implement one of three innovative movement programs and seven Atlanta-area schools were awarded monies for the 2013-2014 school year. The other program called PowerUp! after-school combats childhood obesity in Georgia on the local level by encouraging physical activity and healthier eating habits for Georgia's kids. This initiative is led by the Resurgens Charitable Foundation, whose mission, among others, is to address childhood obesity. Some of PowerUP!'s other partners are the YMCA of Metropolitan Atlanta, fitAtlanta Magazine, and the Georgia Department of Education.

Considering the proactiveness of Atlanta to prevent the obesity epedemic, we opted the city would be one of the finest places for a conference on Childhood Obesity.

Conference Highlights

Childhood Obesity Prevention
Child Nutrition
Childhood Obesity
Rheumatic Diseases
Behavioral & Environmental Factors
Chronic Kidney Disease
Preventing Obesity from Infancy
Pulmonary Function, Allergy & Immunity
Paediatric Infectobesity
Lifelong Effects
Endocrine Disorders & Diabetes
Obesity Surgery
Impact of Steroids & Hormones
Childhood Obesity at Gene Level
Diagnosis & Treatments
Impact on Neurodegenerative Diseases
Visceral & Gastrointestinal Disorders
Vaccines for Obesity
Mushroom Supplement
Antibiotics and Obesity
Cardiac Functional Changes
Current Studies/Research
Healthcare
Exercise & Kinesiology
Biomedical Engineering and Obesity
Underserved Communities
Child Obesity Statistics

Leading Research Funders:

The National Collaborative on Childhood Obesity Research (NCCOR)
The Centers for Disease Control and Prevention (CDC)
The National Institutes of Health (NIH)
The Robert Wood Johnson Foundation (RWJF)
The U.S. Department of Agriculture (USDA)
Dr. Robert C. and Veronica Atkins Foundation
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Rural Assistance Center (RAC)
The International Development Research Centre

Professional and Research Associations in USA

The Boston Nutrition Obesity Research Center (BNORC)
Center for Health and Health Care in Schools (CHHCS), George Washington University.
The New York Obesity Nutrition Research Center
Texas Obesity Research Center
University of Minnesota Obesity Prevention Center
The USC Childhood Obesity Research Center
Rtual Population Obesity Prevention (VPOP) Labs
American Academy of Pediatrics. Committee on Nutrition.
Institute of Medicine. National Research Council of the National Academies.
Georgetown University. Center on an Aging Society
University of California Berkeley. College of Natural Resources. Center for Weight and Health
University of California Berkeley. College of Natural Resources. Center for Weight and Health
American Academy of Pediatrics. Committee on Sports Medicine and Fitness

Organizations in USA

The Obesity Society
Rudd Center for Food Policy & Obesity
National Association of County and City Health Officials (NACCHO)
The Robert Wood Johnson Foundation Center to Prevent Childhood Obesity
American Public Health Association (APHA)
Campaign to End Obesity
The Obesity Action Coalition (OAC)
Food and Nutrition Information Center.
American Medical Association
Bureau of Cancer and Chronic Disease (BCCD)
The Jordan Levin Childhood Obesity Foundation (JLCOF)

International Associations

European Association for the Study of Obesity (EASO)
World Obesity Federation
Global Obesity Prevention Center
World Health Organisation
World Heart Federation
The International Association for the Study of Obesity
The International Diabetes Federation
The International Pediatric Association
The International Union of Nutritional Sciences
The International Development Research Centre
Beth Israel Deaconess Medical Center,
Mayo Clinic & Mayo Foundation,
UT Southwestern Medical Center
Centre for Obesity Research and Education (CORE)

Top Universities in USA

Harvard University
The US Centers for Disease Control and Prevention
University of Washington
Columbia University Johns Hopkins University
The Harvard-affiliated Brigham & Women's Hospital
University of Osaka
University of Pittsburgh
Yale University
University of North Carolina
University of California, Los Angeles
Boston University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
University College London
University of Helsinki

Market Analysis

In 2010, 43 million children (35 million in developing countries) were estimated to be overweight and obese; 92 million were at risk of overweight. The worldwide prevalence of childhood overweight and obesity increased from 4.2% (95% CI: 3.2%, 5.2%) in 1990 to 6.7% (95% CI: 5.6%, 7.7%) in 2010. This trend is expected to reach 9.1% (95% CI: 7.3%, 10.9%), or ’60 million, in 2020.

The weight loss and weight management market is segmented on the basis of diet (meal, beverage, and supplement), equipment (fitness and surgical equipment), and service. The global weight loss and weight management market is expected to reach $206.4 billion by 2019 from $148.1 billion in 2014, growing at a CAGR of 6.9% from 2014 to 2019. The diet segment was expected to account for the largest share of the weight loss and weight management market in 2014.

On the basis of regions, the weight loss and weight management market is segmented into North America, Europe, Asia, and Rest of the World (RoW). In 2014, North America accounted for the largest share of this market owing to the rising obese population, rise in childhood obesity rates, strong government support and funding, lifestyle changes, increase in membership for health clubs, and technological advancements in these regions.

The key market players in the weight loss and weight management market, by diet, include Atkins Nutritionals, Inc. (U.S.), Herbalife Ltd. (U.S.), NutriSystem, Inc. (U.S.), and Kellogg Company (U.S.).Ethicon, Inc. (U.S.), Covidien plc (U.S.), Apollo Endosurgery (U.S.), and Olympus Corporation (Japan) are some of the prominent players in the equipment market, while Brunswick Corporation (U.S.), Amer Sports (Finland), Johnson Health Technology, Ltd. (Taiwan), Cybex International (U.S.), and Technogym Spa (Italy) are the leading players in the fitness equipment segment. The prominent players in the services market are Weight Watchers International, Inc. (U.S.), Jenny Craig (U.S.), eDiets.com (U.S.), VLCC Healthcare Ltd. (India), Slimming World (U.K.), The Gold’s Gym International (U.S.), Duke Diet & Fitness Center (U.S.), 24 hours Fitness (U.S.), Equinox, Inc. (U.S.), Life Time Fitness, Inc. (U.S.), Fitness First Group (U.S.), and Town Sports International Holdings, Inc. (U.S.).

Globally, the weight loss surgery devices market is witnessing significant growth due to increasing obesity epidemic and increasing sedentary lifestyle and junk food habits. Its market was estimated at USD 1,432.4 million in 2014. It is likely to grow at a CAGR of 9.6% from 2014 to 2020 to reach USD 2,489.5 million in 2020. Johnson & Johnson, Medtronic, Inc., Apollo Endosurgery Inc, Aspire Bariatrics, Spatz FGIA Inc., MetaCure and IntraPace Inc are some of the major players of obesity surgery devices market.

Global Anti-obesity Drugs market to grow at a CAGR of 39.45 percent over the period 2014-2019.

Compound annual growth rate of global weight loss and weight management market 2014-2019

National Obesity Rates

Atlanta Obesity Rates

The estimated prevalence of childhood overweight and obesity in Georgia in 2011 was 35.00% and in U.S was 31.3%.

Race and Ethnicity

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	August 29-30, 2016
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

International Conference on Childhood Obesity & Child Development August 29-30, 2016 Atlanta, USA

Recommended Global Obesity Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links